Evidence map›Paper›PMID 36945989›Full record

ArticleTurkish journal of medical sciences2022

Causes of severe infections in patients with systemic sclerosis and associated factors.

Müçteba Enes Yayla, Emine Uslu Yurteri, Murat Torgutalp, Didem Şahin Eroğlu, Serdar Sezer, Ayşe Bahar Keleşoğlu Dinçer, Emine Gözde Aydemir Gülöksüz, Mehmet Levent Yüksel, Recep Yılmaz, Aşkın Ateş and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Müçteba Enes YaylaDepartment of Internal Medicine, Division of Rheumatology, , Ankara Training and Research Hospital, Ankara, Turkey ; Department of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Emine Uslu YurteriDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Murat TorgutalpDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Didem Şahin EroğluDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Serdar SezerDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Ayşe Bahar Keleşoğlu DinçerDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Emine Gözde Aydemir GülöksüzDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Mehmet Levent YükselDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Recep YılmazDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Aşkın AteşDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Tahsin Murat TurgayDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Gülay KınıklıDepartment of Internal Medicine, Division of Rheumatology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Ankara University · TRCenter for Rheumatology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic sclerosis (SSc) is a chronic systemic disease characterized by vascular damage, autoimmunity, and fibrosis in the skin and internal organs. In this study, we tried to determine the causes of severe infection in patients with SSc and to reveal the factors associated with severe infection.

methodsWe retrospectively examined 214 SSc patients between January 2010 and August 2020. Forty-seven patients with at least one severe infection and 167 patients without severe infection were compared.

resultsA total of 76 episodes of severe infections were detected in 47 (22%) patients. Common infections included pneumonia, infected digital ulcer, urinary tract infections, and osteomyelitis. Female patients had a higher frequency in the group without severe infection (91.6% vs. 80.9%, p = 0.035). Patients with severe infections had a higher frequency of digital ulcers (p < 0.001), cardiac (p = 0.002), and GIS involvement (p < 0.001). In multivariable analysis, digital ulcer presence (OR: 2.849 [1.356-5.898] (p = 0.006) and cardiac involvement (OR: 2.801 [1.248-6.285]) were associated with severe infection. Of the patients with severe infections, 34% had recurrent severe infections. There was no difference in demographic and clinical characteristics between patients with recurrent and nonrecurrent severe infections. DISCUSSION: The presence of digital ulcer and cardiac involvement seem to be associated with a severe infection in patients with systemic sclerosis. In patients with cardiac involvement and digital ulcers, more careful attention may be required for the development of severe infections.

Indexed as

Scleroderma, SystemicSkin UlcerFemaleFibrosisHumansRetrospective Studiescardiac involvementdigital ulcerSevere infectionsystemic sclerosis

Identifiers

PMID36945989
PMCPMC10390190
OpenAlexW4312931248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.